人造器官的全球市場 2023-2027
市場調查報告書
商品編碼
1205751

人造器官的全球市場 2023-2027

Global Artificial Organs Market 2023-2027

出版日期: | 出版商: TechNavio | 英文 170 Pages | 訂單完成後即時交付

價格

人造器官的市場規模在2022年~2027年間,預測將成長到130億8,917萬美元,在預測期間內預計將以年複合成長率9.14%成長。

本報告提供人造器官市場整體分析,市場規模與預測,趨勢,成長促進因素·課題,網羅了約25家供應商的供應商分析等資訊。

同時本報告還提供當前全球市場趨勢與推動因素以及整體市場環境的最新分析。市場成長的主要因素有慢性疾病的增加,器官捐贈者的不足,心律調節器和透析器的需求增加。

目錄

第1章 摘要整理

  • 市場概要

第2章 市場形勢

  • 市場生態系統

第3章 市場規模

  • 市場定義
  • 市場區隔分析
  • 市場規模 2022
  • 市場預測:2022-2027年的預測

第4章 市場規模實際成果

  • 全球人造器官市場2017-2021
  • 產品市場區隔分析2017-2021
  • 使用市場區隔分析2017-2021
  • 地區市場區隔分析2017-2021
  • 國家市場區隔分析2017-2021

第5章 波特的五力分析

  • 五力的摘要
  • 買方議價能力
  • 供給企業談判力
  • 新加入廠商業者的威脅
  • 替代品的威脅
  • 競爭的威脅
  • 市場情況

第6章 各產品的市場區隔

  • 市場·市場區隔
  • 各產品比較
  • 人工心臟 - 市場規模與預測 2022-2027
  • 人工腎臟 - 市場規模與預測 2022-2027
  • 人工電子耳 - 市場規模與預測 2022-2027
  • 人工胰臟 - 市場規模與預測 2022-2027
  • 各產品的市場機會

第7章 各用途的市場區隔

  • 市場·市場區隔
  • 各用途比較
  • 置入式 - 市場規模與預測 2022-2027
  • 體外 - 市場規模與預測 2022-2027
  • 各用途的市場機會

第8章 客戶形勢

  • 客戶形勢概要

第9章 各地區形勢

  • 各地區市場區隔
  • 各地區比較
  • 北美 - 市場規模與預測 2022-2027
  • 歐洲 - 市場規模與預測 2022-2027
  • 亞洲 - 市場規模與預測 2022-2027
  • 其他地區(ROW) - 市場規模與預測 2022-2027
  • 美國 - 市場規模與預測 2022-2027
  • 德國 - 市場規模與預測 2022-2027
  • 英國 - 市場規模與預測 2022-2027
  • 日本 - 市場規模與預測 2022-2027
  • 法國 - 市場規模與預測 2022-2027
  • 各地區的市場機會

第10章 促進因素,課題,及趨勢

  • 推動市場要素
  • 市場課題
  • 推動因素與課題的影響
  • 市場趨勢

第11章 業者情勢

  • 概要
  • 業者情勢
  • 混亂狀況
  • 產業的風險

第12章 供應商分析

  • 交易廠商
  • 供應商的市場定位
  • Abbott Laboratories
  • Asahi Kasei Corp.
  • B. Braun SE
  • Baxter International Inc.
  • BioTelemetry Inc.
  • BIOTRONIK SE and Co. KG
  • BiVACOR Inc.
  • Boston Scientific Corp.
  • Cochlear Ltd.
  • F. Hoffmann La Roche Ltd.
  • Fresenius Medical Care AG and Co. KGaA
  • Insulet Corp.
  • MED EL Elektromedizinische Gerate GmbH
  • Medtronic Plc
  • Nipro Pharma Packaging International NV

第13章 附錄

Product Code: IRTNTR44011

Technavio has been monitoring the artificial organs market and is forecast to grow by $13089.17 million during 2022-2027, accelerating at a CAGR of 9.14% during the forecast period. Our report on the artificial organs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence of chronic disorders, shortage of organ donors, and growing demand for pacemakers and dialyzers.

Technavio's artificial organs market is segmented as below:

By Product

  • Artificial heart
  • Artificial kidney
  • Cochlear implants
  • Artificial pancreas

By Usage

  • Implantable
  • Extracorporeal

By Geography

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)

This study identifies the emergence of TAH as one of the prime reasons driving the artificial organs market growth during the next few years. Also, technological advances in artificial organs and growing popularity of home hemodialysis will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the artificial organs market covers the following areas:

  • Artificial organs market sizing
  • Artificial organs market forecast
  • Artificial organs market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading artificial organs market vendors that include Abbott Laboratories, Asahi Kasei Corp., B. Braun SE, Baxter International Inc., BioTelemetry Inc., BIOTRONIK SE and Co. KG, BiVACOR Inc., Boston Scientific Corp., Cochlear Ltd., F. Hoffmann La Roche Ltd., Fresenius Medical Care AG and Co. KGaA, Insulet Corp., MED EL Elektromedizinische Gerate GmbH, Medtronic Plc, Nihon Kohden Corp., Nikkiso Co. Ltd., Nipro Pharma Packaging International NV, Sonova AG, SynCardia Systems LLC, and Tandem Diabetes Care Inc.. Also, the artificial organs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

  • 1.1 Market overview
  • Exhibit 01: Executive Summary - Chart on Market Overview
  • Exhibit 02: Executive Summary - Data Table on Market Overview
  • Exhibit 03: Executive Summary - Chart on Global Market Characteristics
  • Exhibit 04: Executive Summary - Chart on Market by Geography
  • Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
  • Exhibit 06: Executive Summary - Chart on Market Segmentation by Usage
  • Exhibit 07: Executive Summary - Chart on Incremental Growth
  • Exhibit 08: Executive Summary - Data Table on Incremental Growth
  • Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
  • Exhibit 10: Parent market
  • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
  • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
  • Exhibit 13: Market segments
  • 3.3 Market size 2022
  • 3.4 Market outlook: Forecast for 2022-2027
  • Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
  • Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
  • Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
  • Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

  • 4.1 Global artificial organs market 2017 - 2021
  • Exhibit 18: Historic Market Size - Data Table on Global artificial organs market 2017 - 2021 ($ million)
  • 4.2 Product Segment Analysis 2017 - 2021
  • Exhibit 19: Historic Market Size - Product Segment 2017 - 2021 ($ million)
  • 4.3 Usage Segment Analysis 2017 - 2021
  • Exhibit 20: Historic Market Size - Usage Segment 2017 - 2021 ($ million)
  • 4.4 Geography Segment Analysis 2017 - 2021
  • Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
  • 4.5 Country Segment Analysis 2017 - 2021
  • Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

  • 5.1 Five forces summary
  • Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
  • 5.2 Bargaining power of buyers
  • Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
  • 5.3 Bargaining power of suppliers
  • Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
  • 5.4 Threat of new entrants
  • Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
  • 5.5 Threat of substitutes
  • Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
  • 5.6 Threat of rivalry
  • Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
  • 5.7 Market condition
  • Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Product

  • 6.1 Market segments
  • Exhibit 30: Chart on Product - Market share 2022-2027 (%)
  • Exhibit 31: Data Table on Product - Market share 2022-2027 (%)
  • 6.2 Comparison by Product
  • Exhibit 32: Chart on Comparison by Product
  • Exhibit 33: Data Table on Comparison by Product
  • 6.3 Artificial heart - Market size and forecast 2022-2027
  • Exhibit 34: Chart on Artificial heart - Market size and forecast 2022-2027 ($ million)
  • Exhibit 35: Data Table on Artificial heart - Market size and forecast 2022-2027 ($ million)
  • Exhibit 36: Chart on Artificial heart - Year-over-year growth 2022-2027 (%)
  • Exhibit 37: Data Table on Artificial heart - Year-over-year growth 2022-2027 (%)
  • 6.4 Artificial kidney - Market size and forecast 2022-2027
  • Exhibit 38: Chart on Artificial kidney - Market size and forecast 2022-2027 ($ million)
  • Exhibit 39: Data Table on Artificial kidney - Market size and forecast 2022-2027 ($ million)
  • Exhibit 40: Chart on Artificial kidney - Year-over-year growth 2022-2027 (%)
  • Exhibit 41: Data Table on Artificial kidney - Year-over-year growth 2022-2027 (%)
  • 6.5 Cochlear implants - Market size and forecast 2022-2027
  • Exhibit 42: Chart on Cochlear implants - Market size and forecast 2022-2027 ($ million)
  • Exhibit 43: Data Table on Cochlear implants - Market size and forecast 2022-2027 ($ million)
  • Exhibit 44: Chart on Cochlear implants - Year-over-year growth 2022-2027 (%)
  • Exhibit 45: Data Table on Cochlear implants - Year-over-year growth 2022-2027 (%)
  • 6.6 Artificial pancreas - Market size and forecast 2022-2027
  • Exhibit 46: Chart on Artificial pancreas - Market size and forecast 2022-2027 ($ million)
  • Exhibit 47: Data Table on Artificial pancreas - Market size and forecast 2022-2027 ($ million)
  • Exhibit 48: Chart on Artificial pancreas - Year-over-year growth 2022-2027 (%)
  • Exhibit 49: Data Table on Artificial pancreas - Year-over-year growth 2022-2027 (%)
  • 6.7 Market opportunity by Product
  • Exhibit 50: Market opportunity by Product ($ million)

7 Market Segmentation by Usage

  • 7.1 Market segments
  • Exhibit 51: Chart on Usage - Market share 2022-2027 (%)
  • Exhibit 52: Data Table on Usage - Market share 2022-2027 (%)
  • 7.2 Comparison by Usage
  • Exhibit 53: Chart on Comparison by Usage
  • Exhibit 54: Data Table on Comparison by Usage
  • 7.3 Implantable - Market size and forecast 2022-2027
  • Exhibit 55: Chart on Implantable - Market size and forecast 2022-2027 ($ million)
  • Exhibit 56: Data Table on Implantable - Market size and forecast 2022-2027 ($ million)
  • Exhibit 57: Chart on Implantable - Year-over-year growth 2022-2027 (%)
  • Exhibit 58: Data Table on Implantable - Year-over-year growth 2022-2027 (%)
  • 7.4 Extracorporeal - Market size and forecast 2022-2027
  • Exhibit 59: Chart on Extracorporeal - Market size and forecast 2022-2027 ($ million)
  • Exhibit 60: Data Table on Extracorporeal - Market size and forecast 2022-2027 ($ million)
  • Exhibit 61: Chart on Extracorporeal - Year-over-year growth 2022-2027 (%)
  • Exhibit 62: Data Table on Extracorporeal - Year-over-year growth 2022-2027 (%)
  • 7.5 Market opportunity by Usage
  • Exhibit 63: Market opportunity by Usage ($ million)

8 Customer Landscape

  • 8.1 Customer landscape overview
  • Exhibit 64: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

  • 9.1 Geographic segmentation
  • Exhibit 65: Chart on Market share by geography 2022-2027 (%)
  • Exhibit 66: Data Table on Market share by geography 2022-2027 (%)
  • 9.2 Geographic comparison
  • Exhibit 67: Chart on Geographic comparison
  • Exhibit 68: Data Table on Geographic comparison
  • 9.3 North America - Market size and forecast 2022-2027
  • Exhibit 69: Chart on North America - Market size and forecast 2022-2027 ($ million)
  • Exhibit 70: Data Table on North America - Market size and forecast 2022-2027 ($ million)
  • Exhibit 71: Chart on North America - Year-over-year growth 2022-2027 (%)
  • Exhibit 72: Data Table on North America - Year-over-year growth 2022-2027 (%)
  • 9.4 Europe - Market size and forecast 2022-2027
  • Exhibit 73: Chart on Europe - Market size and forecast 2022-2027 ($ million)
  • Exhibit 74: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
  • Exhibit 75: Chart on Europe - Year-over-year growth 2022-2027 (%)
  • Exhibit 76: Data Table on Europe - Year-over-year growth 2022-2027 (%)
  • 9.5 Asia - Market size and forecast 2022-2027
  • Exhibit 77: Chart on Asia - Market size and forecast 2022-2027 ($ million)
  • Exhibit 78: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
  • Exhibit 79: Chart on Asia - Year-over-year growth 2022-2027 (%)
  • Exhibit 80: Data Table on Asia - Year-over-year growth 2022-2027 (%)
  • 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
  • Exhibit 81: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
  • Exhibit 82: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
  • Exhibit 83: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
  • Exhibit 84: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
  • 9.7 US - Market size and forecast 2022-2027
  • Exhibit 85: Chart on US - Market size and forecast 2022-2027 ($ million)
  • Exhibit 86: Data Table on US - Market size and forecast 2022-2027 ($ million)
  • Exhibit 87: Chart on US - Year-over-year growth 2022-2027 (%)
  • Exhibit 88: Data Table on US - Year-over-year growth 2022-2027 (%)
  • 9.8 Germany - Market size and forecast 2022-2027
  • Exhibit 89: Chart on Germany - Market size and forecast 2022-2027 ($ million)
  • Exhibit 90: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
  • Exhibit 91: Chart on Germany - Year-over-year growth 2022-2027 (%)
  • Exhibit 92: Data Table on Germany - Year-over-year growth 2022-2027 (%)
  • 9.9 UK - Market size and forecast 2022-2027
  • Exhibit 93: Chart on UK - Market size and forecast 2022-2027 ($ million)
  • Exhibit 94: Data Table on UK - Market size and forecast 2022-2027 ($ million)
  • Exhibit 95: Chart on UK - Year-over-year growth 2022-2027 (%)
  • Exhibit 96: Data Table on UK - Year-over-year growth 2022-2027 (%)
  • 9.10 Japan - Market size and forecast 2022-2027
  • Exhibit 97: Chart on Japan - Market size and forecast 2022-2027 ($ million)
  • Exhibit 98: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
  • Exhibit 99: Chart on Japan - Year-over-year growth 2022-2027 (%)
  • Exhibit 100: Data Table on Japan - Year-over-year growth 2022-2027 (%)
  • 9.11 France - Market size and forecast 2022-2027
  • Exhibit 101: Chart on France - Market size and forecast 2022-2027 ($ million)
  • Exhibit 102: Data Table on France - Market size and forecast 2022-2027 ($ million)
  • Exhibit 103: Chart on France - Year-over-year growth 2022-2027 (%)
  • Exhibit 104: Data Table on France - Year-over-year growth 2022-2027 (%)
  • 9.12 Market opportunity by geography
  • Exhibit 105: Market opportunity by geography ($ million)

10 Drivers, Challenges, and Trends

  • 10.1 Market drivers
  • 10.2 Market challenges
  • 10.3 Impact of drivers and challenges
  • Exhibit 106: Impact of drivers and challenges in 2022 and 2027
  • 10.4 Market trends

11 Vendor Landscape

  • 11.1 Overview
  • 11.2 Vendor landscape
  • Exhibit 107: Overview on Criticality of inputs and Factors of differentiation
  • 11.3 Landscape disruption
  • Exhibit 108: Overview on factors of disruption
  • 11.4 Industry risks
  • Exhibit 109: Impact of key risks on business

12 Vendor Analysis

  • 12.1 Vendors covered
  • Exhibit 110: Vendors covered
  • 12.2 Market positioning of vendors
  • Exhibit 111: Matrix on vendor position and classification
  • 12.3 Abbott Laboratories
  • Exhibit 112: Abbott Laboratories - Overview
  • Exhibit 113: Abbott Laboratories - Business segments
  • Exhibit 114: Abbott Laboratories - Key news
  • Exhibit 115: Abbott Laboratories - Key offerings
  • Exhibit 116: Abbott Laboratories - Segment focus
  • 12.4 Asahi Kasei Corp.
  • Exhibit 117: Asahi Kasei Corp. - Overview
  • Exhibit 118: Asahi Kasei Corp. - Business segments
  • Exhibit 119: Asahi Kasei Corp. - Key news
  • Exhibit 120: Asahi Kasei Corp. - Key offerings
  • Exhibit 121: Asahi Kasei Corp. - Segment focus
  • 12.5 B. Braun SE
  • Exhibit 122: B. Braun SE - Overview
  • Exhibit 123: B. Braun SE - Business segments
  • Exhibit 124: B. Braun SE - Key news
  • Exhibit 125: B. Braun SE - Key offerings
  • Exhibit 126: B. Braun SE - Segment focus
  • 12.6 Baxter International Inc.
  • Exhibit 127: Baxter International Inc. - Overview
  • Exhibit 128: Baxter International Inc. - Business segments
  • Exhibit 129: Baxter International Inc. - Key news
  • Exhibit 130: Baxter International Inc. - Key offerings
  • Exhibit 131: Baxter International Inc. - Segment focus
  • 12.7 BioTelemetry Inc.
  • Exhibit 132: BioTelemetry Inc. - Overview
  • Exhibit 133: BioTelemetry Inc. - Product / Service
  • Exhibit 134: BioTelemetry Inc. - Key offerings
  • 12.8 BIOTRONIK SE and Co. KG
  • Exhibit 135: BIOTRONIK SE and Co. KG - Overview
  • Exhibit 136: BIOTRONIK SE and Co. KG - Product / Service
  • Exhibit 137: BIOTRONIK SE and Co. KG - Key offerings
  • 12.9 BiVACOR Inc.
  • Exhibit 138: BiVACOR Inc. - Overview
  • Exhibit 139: BiVACOR Inc. - Product / Service
  • Exhibit 140: BiVACOR Inc. - Key offerings
  • 12.10 Boston Scientific Corp.
  • Exhibit 141: Boston Scientific Corp. - Overview
  • Exhibit 142: Boston Scientific Corp. - Business segments
  • Exhibit 143: Boston Scientific Corp. - Key news
  • Exhibit 144: Boston Scientific Corp. - Key offerings
  • Exhibit 145: Boston Scientific Corp. - Segment focus
  • 12.11 Cochlear Ltd.
  • Exhibit 146: Cochlear Ltd. - Overview
  • Exhibit 147: Cochlear Ltd. - Business segments
  • Exhibit 148: Cochlear Ltd. - Key offerings
  • Exhibit 149: Cochlear Ltd. - Segment focus
  • 12.12 F. Hoffmann La Roche Ltd.
  • Exhibit 150: F. Hoffmann La Roche Ltd. - Overview
  • Exhibit 151: F. Hoffmann La Roche Ltd. - Business segments
  • Exhibit 152: F. Hoffmann La Roche Ltd. - Key news
  • Exhibit 153: F. Hoffmann La Roche Ltd. - Key offerings
  • Exhibit 154: F. Hoffmann La Roche Ltd. - Segment focus
  • 12.13 Fresenius Medical Care AG and Co. KGaA
  • Exhibit 155: Fresenius Medical Care AG and Co. KGaA - Overview
  • Exhibit 156: Fresenius Medical Care AG and Co. KGaA - Business segments
  • Exhibit 157: Fresenius Medical Care AG and Co. KGaA - Key news
  • Exhibit 158: Fresenius Medical Care AG and Co. KGaA - Key offerings
  • Exhibit 159: Fresenius Medical Care AG and Co. KGaA - Segment focus
  • 12.14 Insulet Corp.
  • Exhibit 160: Insulet Corp. - Overview
  • Exhibit 161: Insulet Corp. - Product / Service
  • Exhibit 162: Insulet Corp. - Key news
  • Exhibit 163: Insulet Corp. - Key offerings
  • 12.15 MED EL Elektromedizinische Gerate GmbH
  • Exhibit 164: MED EL Elektromedizinische Gerate GmbH - Overview
  • Exhibit 165: MED EL Elektromedizinische Gerate GmbH - Product / Service
  • Exhibit 166: MED EL Elektromedizinische Gerate GmbH - Key offerings
  • 12.16 Medtronic Plc
  • Exhibit 167: Medtronic Plc - Overview
  • Exhibit 168: Medtronic Plc - Business segments
  • Exhibit 169: Medtronic Plc - Key news
  • Exhibit 170: Medtronic Plc - Key offerings
  • Exhibit 171: Medtronic Plc - Segment focus
  • 12.17 Nipro Pharma Packaging International NV
  • Exhibit 172: Nipro Pharma Packaging International NV - Overview
  • Exhibit 173: Nipro Pharma Packaging International NV - Business segments
  • Exhibit 174: Nipro Pharma Packaging International NV - Key news
  • Exhibit 175: Nipro Pharma Packaging International NV - Key offerings
  • Exhibit 176: Nipro Pharma Packaging International NV - Segment focus

13 Appendix

  • 13.1 Scope of the report
  • 13.2 Inclusions and exclusions checklist
  • Exhibit 177: Inclusions checklist
  • Exhibit 178: Exclusions checklist
  • 13.3 Currency conversion rates for US$
  • Exhibit 179: Currency conversion rates for US$
  • 13.4 Research methodology
  • Exhibit 180: Research methodology
  • Exhibit 181: Validation techniques employed for market sizing
  • Exhibit 182: Information sources
  • 13.5 List of abbreviations
  • Exhibit 183: List of abbreviations
    • In October, the company appointed Wayne A. I. Frederick to its board of directors.

Exhibits:

  • Exhibits1: Executive Summary - Chart on Market Overview
  • Exhibits2: Executive Summary - Data Table on Market Overview
  • Exhibits3: Executive Summary - Chart on Global Market Characteristics
  • Exhibits4: Executive Summary - Chart on Market by Geography
  • Exhibits5: Executive Summary - Chart on Market Segmentation by Product
  • Exhibits6: Executive Summary - Chart on Market Segmentation by Usage
  • Exhibits7: Executive Summary - Chart on Incremental Growth
  • Exhibits8: Executive Summary - Data Table on Incremental Growth
  • Exhibits9: Executive Summary - Chart on Vendor Market Positioning
  • Exhibits10: Parent market
  • Exhibits11: Market Characteristics
  • Exhibits12: Offerings of vendors included in the market definition
  • Exhibits13: Market segments
  • Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
  • Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
  • Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
  • Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
  • Exhibits18: Historic Market Size - Data Table on Global artificial organs market 2017 - 2021 ($ million)
  • Exhibits19: Historic Market Size - Product Segment 2017 - 2021 ($ million)
  • Exhibits20: Historic Market Size - Usage Segment 2017 - 2021 ($ million)
  • Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
  • Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
  • Exhibits23: Five forces analysis - Comparison between 2022 and 2027
  • Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
  • Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
  • Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
  • Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
  • Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
  • Exhibits29: Chart on Market condition - Five forces 2022 and 2027
  • Exhibits30: Chart on Product - Market share 2022-2027 (%)
  • Exhibits31: Data Table on Product - Market share 2022-2027 (%)
  • Exhibits32: Chart on Comparison by Product
  • Exhibits33: Data Table on Comparison by Product
  • Exhibits34: Chart on Artificial heart - Market size and forecast 2022-2027 ($ million)
  • Exhibits35: Data Table on Artificial heart - Market size and forecast 2022-2027 ($ million)
  • Exhibits36: Chart on Artificial heart - Year-over-year growth 2022-2027 (%)
  • Exhibits37: Data Table on Artificial heart - Year-over-year growth 2022-2027 (%)
  • Exhibits38: Chart on Artificial kidney - Market size and forecast 2022-2027 ($ million)
  • Exhibits39: Data Table on Artificial kidney - Market size and forecast 2022-2027 ($ million)
  • Exhibits40: Chart on Artificial kidney - Year-over-year growth 2022-2027 (%)
  • Exhibits41: Data Table on Artificial kidney - Year-over-year growth 2022-2027 (%)
  • Exhibits42: Chart on Cochlear implants - Market size and forecast 2022-2027 ($ million)
  • Exhibits43: Data Table on Cochlear implants - Market size and forecast 2022-2027 ($ million)
  • Exhibits44: Chart on Cochlear implants - Year-over-year growth 2022-2027 (%)
  • Exhibits45: Data Table on Cochlear implants - Year-over-year growth 2022-2027 (%)
  • Exhibits46: Chart on Artificial pancreas - Market size and forecast 2022-2027 ($ million)
  • Exhibits47: Data Table on Artificial pancreas - Market size and forecast 2022-2027 ($ million)
  • Exhibits48: Chart on Artificial pancreas - Year-over-year growth 2022-2027 (%)
  • Exhibits49: Data Table on Artificial pancreas - Year-over-year growth 2022-2027 (%)
  • Exhibits50: Market opportunity by Product ($ million)
  • Exhibits51: Chart on Usage - Market share 2022-2027 (%)
  • Exhibits52: Data Table on Usage - Market share 2022-2027 (%)
  • Exhibits53: Chart on Comparison by Usage
  • Exhibits54: Data Table on Comparison by Usage
  • Exhibits55: Chart on Implantable - Market size and forecast 2022-2027 ($ million)
  • Exhibits56: Data Table on Implantable - Market size and forecast 2022-2027 ($ million)
  • Exhibits57: Chart on Implantable - Year-over-year growth 2022-2027 (%)
  • Exhibits58: Data Table on Implantable - Year-over-year growth 2022-2027 (%)
  • Exhibits59: Chart on Extracorporeal - Market size and forecast 2022-2027 ($ million)
  • Exhibits60: Data Table on Extracorporeal - Market size and forecast 2022-2027 ($ million)
  • Exhibits61: Chart on Extracorporeal - Year-over-year growth 2022-2027 (%)
  • Exhibits62: Data Table on Extracorporeal - Year-over-year growth 2022-2027 (%)
  • Exhibits63: Market opportunity by Usage ($ million)
  • Exhibits64: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits65: Chart on Market share by geography 2022-2027 (%)
  • Exhibits66: Data Table on Market share by geography 2022-2027 (%)
  • Exhibits67: Chart on Geographic comparison
  • Exhibits68: Data Table on Geographic comparison
  • Exhibits69: Chart on North America - Market size and forecast 2022-2027 ($ million)
  • Exhibits70: Data Table on North America - Market size and forecast 2022-2027 ($ million)
  • Exhibits71: Chart on North America - Year-over-year growth 2022-2027 (%)
  • Exhibits72: Data Table on North America - Year-over-year growth 2022-2027 (%)
  • Exhibits73: Chart on Europe - Market size and forecast 2022-2027 ($ million)
  • Exhibits74: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
  • Exhibits75: Chart on Europe - Year-over-year growth 2022-2027 (%)
  • Exhibits76: Data Table on Europe - Year-over-year growth 2022-2027 (%)
  • Exhibits77: Chart on Asia - Market size and forecast 2022-2027 ($ million)
  • Exhibits78: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
  • Exhibits79: Chart on Asia - Year-over-year growth 2022-2027 (%)
  • Exhibits80: Data Table on Asia - Year-over-year growth 2022-2027 (%)
  • Exhibits81: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
  • Exhibits82: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
  • Exhibits83: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
  • Exhibits84: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
  • Exhibits85: Chart on US - Market size and forecast 2022-2027 ($ million)
  • Exhibits86: Data Table on US - Market size and forecast 2022-2027 ($ million)
  • Exhibits87: Chart on US - Year-over-year growth 2022-2027 (%)
  • Exhibits88: Data Table on US - Year-over-year growth 2022-2027 (%)
  • Exhibits89: Chart on Germany - Market size and forecast 2022-2027 ($ million)
  • Exhibits90: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
  • Exhibits91: Chart on Germany - Year-over-year growth 2022-2027 (%)
  • Exhibits92: Data Table on Germany - Year-over-year growth 2022-2027 (%)
  • Exhibits93: Chart on UK - Market size and forecast 2022-2027 ($ million)
  • Exhibits94: Data Table on UK - Market size and forecast 2022-2027 ($ million)
  • Exhibits95: Chart on UK - Year-over-year growth 2022-2027 (%)
  • Exhibits96: Data Table on UK - Year-over-year growth 2022-2027 (%)
  • Exhibits97: Chart on Japan - Market size and forecast 2022-2027 ($ million)
  • Exhibits98: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
  • Exhibits99: Chart on Japan - Year-over-year growth 2022-2027 (%)
  • Exhibits100: Data Table on Japan - Year-over-year growth 2022-2027 (%)
  • Exhibits101: Chart on France - Market size and forecast 2022-2027 ($ million)
  • Exhibits102: Data Table on France - Market size and forecast 2022-2027 ($ million)
  • Exhibits103: Chart on France - Year-over-year growth 2022-2027 (%)
  • Exhibits104: Data Table on France - Year-over-year growth 2022-2027 (%)
  • Exhibits105: Market opportunity by geography ($ million)
  • Exhibits106: Impact of drivers and challenges in 2022 and 2027
  • Exhibits107: Overview on Criticality of inputs and Factors of differentiation
  • Exhibits108: Overview on factors of disruption
  • Exhibits109: Impact of key risks on business
  • Exhibits110: Vendors covered
  • Exhibits111: Matrix on vendor position and classification
  • Exhibits112: Abbott Laboratories - Overview
  • Exhibits113: Abbott Laboratories - Business segments
  • Exhibits114: Abbott Laboratories - Key news
  • Exhibits115: Abbott Laboratories - Key offerings
  • Exhibits116: Abbott Laboratories - Segment focus
  • Exhibits117: Asahi Kasei Corp. - Overview
  • Exhibits118: Asahi Kasei Corp. - Business segments
  • Exhibits119: Asahi Kasei Corp. - Key news
  • Exhibits120: Asahi Kasei Corp. - Key offerings
  • Exhibits121: Asahi Kasei Corp. - Segment focus
  • Exhibits122: B. Braun SE - Overview
  • Exhibits123: B. Braun SE - Business segments
  • Exhibits124: B. Braun SE - Key news
  • Exhibits125: B. Braun SE - Key offerings
  • Exhibits126: B. Braun SE - Segment focus
  • Exhibits127: Baxter International Inc. - Overview
  • Exhibits128: Baxter International Inc. - Business segments
  • Exhibits129: Baxter International Inc. - Key news
  • Exhibits130: Baxter International Inc. - Key offerings
  • Exhibits131: Baxter International Inc. - Segment focus
  • Exhibits132: BioTelemetry Inc. - Overview
  • Exhibits133: BioTelemetry Inc. - Product / Service
  • Exhibits134: BioTelemetry Inc. - Key offerings
  • Exhibits135: BIOTRONIK SE and Co. KG - Overview
  • Exhibits136: BIOTRONIK SE and Co. KG - Product / Service
  • Exhibits137: BIOTRONIK SE and Co. KG - Key offerings
  • Exhibits138: BiVACOR Inc. - Overview
  • Exhibits139: BiVACOR Inc. - Product / Service
  • Exhibits140: BiVACOR Inc. - Key offerings
  • Exhibits141: Boston Scientific Corp. - Overview
  • Exhibits142: Boston Scientific Corp. - Business segments
  • Exhibits143: Boston Scientific Corp. - Key news
  • Exhibits144: Boston Scientific Corp. - Key offerings
  • Exhibits145: Boston Scientific Corp. - Segment focus
  • Exhibits146: Cochlear Ltd. - Overview
  • Exhibits147: Cochlear Ltd. - Business segments
  • Exhibits148: Cochlear Ltd. - Key offerings
  • Exhibits149: Cochlear Ltd. - Segment focus
  • Exhibits150: F. Hoffmann La Roche Ltd. - Overview
  • Exhibits151: F. Hoffmann La Roche Ltd. - Business segments
  • Exhibits152: F. Hoffmann La Roche Ltd. - Key news
  • Exhibits153: F. Hoffmann La Roche Ltd. - Key offerings
  • Exhibits154: F. Hoffmann La Roche Ltd. - Segment focus
  • Exhibits155: Fresenius Medical Care AG and Co. KGaA - Overview
  • Exhibits156: Fresenius Medical Care AG and Co. KGaA - Business segments
  • Exhibits157: Fresenius Medical Care AG and Co. KGaA - Key news
  • Exhibits158: Fresenius Medical Care AG and Co. KGaA - Key offerings
  • Exhibits159: Fresenius Medical Care AG and Co. KGaA - Segment focus
  • Exhibits160: Insulet Corp. - Overview
  • Exhibits161: Insulet Corp. - Product / Service
  • Exhibits162: Insulet Corp. - Key news
  • Exhibits163: Insulet Corp. - Key offerings
  • Exhibits164: MED EL Elektromedizinische Gerate GmbH - Overview
  • Exhibits165: MED EL Elektromedizinische Gerate GmbH - Product / Service
  • Exhibits166: MED EL Elektromedizinische Gerate GmbH - Key offerings
  • Exhibits167: Medtronic Plc - Overview
  • Exhibits168: Medtronic Plc - Business segments
  • Exhibits169: Medtronic Plc - Key news
  • Exhibits170: Medtronic Plc - Key offerings
  • Exhibits171: Medtronic Plc - Segment focus
  • Exhibits172: Nipro Pharma Packaging International NV - Overview
  • Exhibits173: Nipro Pharma Packaging International NV - Business segments
  • Exhibits174: Nipro Pharma Packaging International NV - Key news
  • Exhibits175: Nipro Pharma Packaging International NV - Key offerings
  • Exhibits176: Nipro Pharma Packaging International NV - Segment focus
  • Exhibits177: Inclusions checklist
  • Exhibits178: Exclusions checklist
  • Exhibits179: Currency conversion rates for US$
  • Exhibits180: Research methodology
  • Exhibits181: Validation techniques employed for market sizing
  • Exhibits182: Information sources
  • Exhibits183: List of abbreviations